Adverum Biotechnologies
ADVM
ADVM
76 hedge funds and large institutions have $62.3M invested in Adverum Biotechnologies in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less funds holding
Funds holding: 77 → 76 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $37K
Holders
76
Holding in Top 10
1
Calls
–
Puts
$37K
Top Buyers
| 1 | +$3.89M | |
| 2 | +$1.11M | |
| 3 | +$827K | |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
+$446K |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$372K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$1.55M | |
| 3 | -$615K | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$589K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$444K |